Nitric Oxide-Releasing Solution for Foot Ulcer

"Affirmative, clinicaltrials.gov data demonstrates that this experiment is currently enrolling participants. It was initially advertised on February 23rd 2021 and its details have been most recently adjusted on October 27th 2022. The trial requires 40 individuals to be recruited at a single medical centre."

"Affirmative. Information located on clinicaltrials.gov confirms that this research is proceeding and looking to recruit 40 patients from 1 centre. The trial was initially announced on February 23rd 2021, with the most recent update having been posted October 27th 2022."

"Currently, 21 trials are actively researching the benefits of Nitric Oxide-Releasing Solution with 8 in Phase 3. Anchorage, Alaska is home to most studies; however 97 other sites across the globe have performed experiments on this subject."

"This clinical trial, which is slated to be completed within 29 days, aims to quantify the amount of methemoglobin present during NORS treatment in people with DFU. As secondary objectives, researchers are looking into how effective NORS is compared to placebo when it comes reducing bacterial loads and wound-related infections among participants; they will measure this by gauging mean changes in percentage of microbial species as well as comparing proportions of patients who report a resolution in their symptoms."